{name}
{subtitle}
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~13 mi. (Fitchburg, Massachusetts, +825 more cities)
facility
Simonds-Sinon Regional Cancer Center
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
city
~13 mi. (Fitchburg, Massachusetts, +954 more cities)
facility
Simonds-Sinon Regional Cancer Center
drug
crizotinib, +4 more drugs
drug type
chemotherapy, +2 more types
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
city
~13 mi. (Fitchburg, Massachusetts, +444 more cities)
facility
Simonds-Sinon Regional Cancer Center
drug
abiraterone, +3 more drugs
drug type
chemotherapy, +1 more type
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
city
~22 mi. (Lowell, Massachusetts, +577 more cities)
facility
Lowell General Hospital